Have a personal or library account? Click to login
A Metric Approach to Hot Topics in Biomedicine via Keyword Co-occurrence Cover

A Metric Approach to Hot Topics in Biomedicine via Keyword Co-occurrence

By: Jane H. Qin,  Jean J. Wang and  Fred Y. Ye  
Open Access
|Dec 2019

Figures & Tables

Figure 1

Co-occurrence network with the highest h-index keywords in the field of CRISPR/Cas9.
Co-occurrence network with the highest h-index keywords in the field of CRISPR/Cas9.

Figure 2

Co-occurrence network with the highest h-index keywords in the field of iPS cell.
Co-occurrence network with the highest h-index keywords in the field of iPS cell.

Figure 3

Co-occurrence network with the highest h-index keywords in the field of synthetic biology.
Co-occurrence network with the highest h-index keywords in the field of synthetic biology.

Co-occurrence network centrality with the highest h-index keywords in the field of iPS cell_

RankKeywordDegree CentralityKeywordBetweenness Centrality
1STEM CELL184STEM CELL359.39
2EMBRYONIC STEM CELL170EMBRYONIC STEM CELL267.07
3REPROGRAMMING166HUMAN IPSC254.20
4HUMAN IPSC162REPROGRAMMING246.40
5PLURIPOTENT STEM CELL160DIFFERENTIATION225.41
6DIFFERENTIATION158PLURIPOTENT STEM CELL221.89
7REGENERATIVE MEDICINE118HUMAN EMBRYONIC STEM CELL110.40
8HUMAN EMBRYONIC STEM CELL116REGENERATIVE MEDICINE100.92
9NEURAL STEM CELL116MESENCHYMAL STEM CELL94.19
10MESENCHYMAL STEM CELL114NEURAL STEM CELL83.66
11CELL THERAPY102TRANSPLANTATION70.11
12PLURIPOTENCY102PLURIPOTENCY67.90
13TRANSPLANTATION102CELL THERAPY60.74
14TISSUE ENGINEERING98CARDIOMYOCYTES58.25
15CARDIOMYOCYTES90NEURON56.58
16NEURON90TISSUE ENGINEERING54.92
17DISEASE MODELING82HIPSC43.86
18HIPSC82DRUG SCREENING42.39
19PARKINSON’S DISEASE82GENE EXPRESSION40.25
20GENE EXPRESSION80DISEASE MODELING37.50

Co-occurrence network centrality with the highest h-index keywords in the field of synthetic biology_

RankKeywordDegreeKeywordBetweennes
CentralityCentrality
1METABOLIC ENGINEERING100METABOLIC ENGINEERING378.42
2YEAST90GENE EXPRESSION312.93
3GENE CIRCUIT82YEAST286.57
4ES CELLHERICHIA COLI80GENE CIRCUIT281.48
5GENE EXPRESSION80ES CELLHERICHIA COLI249.28
6SACCHAROMYCES CEREVISIAE80SACCHAROMYCES CEREVISIAE229.17
7PROTEIN ENGINEERING66SYNTHETIC GENE180.28
8DIRECTED EVOLUTION62PROTEIN ENGINEERING171.01
9GENE REGULATION60CELL CYCLE169.32
10SYNTHETIC GENE60GENE THERAPY158.88
11SYSTEMS BIOLOGY60TRANSCRIPTION146.23
12TRANSCRIPTION60DIRECTED EVOLUTION143.33
13GENE ENGINEERING56SYSTEMS BIOLOGY130.95
14BIOTECHNOLOGY50GENE REGULATION108.56
15GENE THERAPY50GENE ENGINEERING90.24
16CRISPR/CAS948ESSENTIAL GENE87.67
17CYANOBACTERIA46CELL-FREE PROTEIN SYNTHESIS76.44
18ESSENTIAL GENE46EVOLUTION71.90
19EVOLUTION44TRANSCRIPTION FACTOR70.90
20E. COLI42BIOTECHNOLOGY66.57

Co-occurrence network centrality with the highest h-index keywords in the field of CRISPR/Cas9_

RankKeywordDegree CentralityKeywordBetweenness Centrality
1CRISPR188CRISPR1,378.00
2GENOME EDITING156GENOME EDITING664.00
3CRISPR/CAS132CRISPR/CAS441.37
4GENOME ENGINEERING94GENOME ENGINEERING157.52
5HOMOLOGOUS RECOMBINATION84GENES135.44
6GENES76HOMOLOGOUS RECOMBINATION111.44
7ZEBRAFISH70ZEBRAFISH110.97
8GENE TARGET66GENE REGULATION60.97
9TALEN64CRISPRI53.39
10SYNTHETIC BIOLOGY58APOPTOSIS49.33
11GENE REGULATION56DNA REPAIR48.34
12GENE THERAPY56SYNTHETIC BIOLOGY47.97
13DNA REPAIR54GENE TARGET47.13
14GENE KNOCKOUT54IPSC42.64
15IPSC50GENE KNOCKOUT41.15
16ZFN50TALEN41.09
17SGRNA46GENE THERAPY39.40
18CANCER42EVOLUTION37.89
19CRRNA42SGRNA34.15
20EVOLUTION42CANCER34.14
DOI: https://doi.org/10.2478/jdis-2019-0018 | Journal eISSN: 2543-683X | Journal ISSN: 2096-157X
Language: English
Page range: 13 - 25
Submitted on: Sep 24, 2019
Accepted on: Nov 24, 2019
Published on: Dec 27, 2019
Published by: Chinese Academy of Sciences, National Science Library
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Jane H. Qin, Jean J. Wang, Fred Y. Ye, published by Chinese Academy of Sciences, National Science Library
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.